Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 336

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 336
---
                  |     |              | 0.51 |     |              |  8,755 |   |     |              |  2,437 |   |
| Pfizer Inc. (NYSE:PFE)                             |     |              | 0.63 |     |              |    319 |   |     |              | (1,600 | ) |
| Eli Lilly and Company (NYSE:LLY)                   |     |              | 0.41 |     |              | 13,262 |   |     |              |  1,647 |   |
| Viatris Inc. (NasdaqGS:VTRS)                       |     |              | 0.94 |     |              |  1,340 |   |     |              |      7 |   |
| Teva Pharmaceutical Industries Limited (NYSE:TEVA) |     |              | 0.90 |     |              |  2,459 |   |     |              |    606 |   |
| Dr. Reddy’s Laboratories Limited (BSE:500124)      |     |              | 0.34 |     |              |    758 |   |     |              |    198 |   |
| Collegium Pharmaceutical, Inc. (NasdaqGS:COLL)     |     |              | 0.93 |     |              |    131 |   |     |              |     41 |   |
| AbbVie Inc. (NYSE:ABBV)                            |     |              | 0.62 |     |              | 15,100 |   |     |              |  1,716 |   |
| Axsome Therapeutics, Inc. (NasdaqGM:AXSM)          |     |              | 1.25 |     |              |   (266 | ) |     |              |     (1 | ) |

Notes:

| (1) | Values in thousands of US dollars, except beta data. |

| (2) | Corresponding values continued in table below. |

| (3) | Source: S&P Capital IQ. |

Beta Calculation Information (Continued)

| Comparable Company Names                           |     | Effective 
 Tax Rate  |      |   |     | If Tax Rate = 
 “NM”, Use:    |      |   |     | Pre-Tax      
 Cost of Debt |      |   |     | After-Tax Cost of 
 Debt